New Retina Radio by Eyetube

By: Retina Today
Listen for free

  • Summary

  • New Retina Radio is a place to hear stories about retina that are told nowhere else.
    2024 Bryn Mawr Communications LLC
    Show more Show less
Science
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?

    New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?
    Nov 21 2024
    Does metformin use reduce the risk of developing AMD in non-diabetic patients? Moderator Rebecca Soares, MD, and panelists Matt Starr, MD, and Nikisha Kothari, MD, review a decade-long case control-control study assessing risk of AMD in non-diabetic patients who have been taking metformin for any reason. They ask whether the study's blindspots undercut its findings, and speculate what other questions further research could answer.
    Show more Show less
    15 mins
  • AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA

    AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA
    Nov 14 2024
    We’ve got to keep our eye on the pipeline. What do the latest data tell us about two drug candidates? Durga Borkar, MD, MMCi, reviews data from a phase 2 study assessing the safety and efficacy ONL1204 (ONL Therapeutics) delivered prior to RRD surgery. Did injecting ONL1204, which prevents Fas activation, lead to any postsurgical differences? Alex Melamud stops by to discuss the phase 2/3 SAGA study assessing the safety and efficacy of gildeuretinol (Alkeus Pharmaceuticals), an oral agent for the treatment of geographic atrophy. Can this drug succeed where other oral options in retina have failed?
    Show more Show less
    20 mins
  • AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

    AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD
    Nov 7 2024
    The ELEVATUM study exclusively enrolled historically underrepresented patients in a study assessing faricimab (Vabysmo, Genentech/Roche) for DME. Were there any surprises in the data? Jeremiah Brown, MD, MS, sits down with New Retina Radio to review the philosophy behind the ELEVATUM study, discuss the study’s findings, and preview the next phases of the trial. And Eric Schneider, MD, joins the program to discuss the findings of a pivotal study assessing home OCT (Scanly, Notal Vision) in wet AMD patients. Is home OCT equivalent to in-office OCT when it comes to visualization? And do expert graders agree with an AI algorithm’s assessments of patient’s pathology?
    Show more Show less
    25 mins

What listeners say about New Retina Radio by Eyetube

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available